Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes

International Journal of Cancer

Volumn 134, Issue 1, 2014, Pages 81-91

  Kinseth, Matthew A ^a   Jia, Zhenyu ^b,c   Rahmatpanah, Farahnaz ^b   Sawyers, Anne ^b   Sutton, Manuel ^b   Wang Rodriguez, Jessica ^d   Mercola, Dan ^b   McGuire, Kathleen L ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GUIZHOU EDUCATION UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

EMT; immune response; prostate cancer; racial disparity; stroma expression

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; ELASTIN; FIBULIN 5; INTEGRIN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; ONCOSTATIN M; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER TISSUE; CAUCASIAN; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; STROMA; UPREGULATION;

EMT; IMMUNE RESPONSE; PROSTATE CANCER; RACIAL DISPARITY; STROMA EXPRESSION;

AFRICAN AMERICANS; EPITHELIAL-MESENCHYMAL TRANSITION; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATIC NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANSCRIPTOME; TUMOR MICROENVIRONMENT;

EID: 84885949199     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28326     Document Type: Article

References (34)

1. Marlow NM, Halpern MT, Pavluck AL, et al. Disparities associated with advanced prostate cancer stage at diagnosis. J Health Care Poor Underserved 2010; 21: 112-31.
2. Chornokur G, Dalton K, Borysova ME, et al. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate 2011; 71: 985-97.
3. Powell IJ,. Prostate cancer in the African American: is this a different disease? Semin Urol Oncol 1998; 16: 221-6.
4. Ricks-Santi L, Mason T, Apprey V, et al. p53 Pro72Arg polymorphism and prostate cancer in men of African descent. Prostate 2010; 70: 1739-45.
5. Guo Y, Sigman DB, Borkowski A, et al. Racial differences in prostate cancer growth: apoptosis and cell proliferation in Caucasian and African-American patients. Prostate 2000; 42: 130-6.
6. Wallace TA, Prueitt RL, Yi M, et al. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res 2008; 68: 927-36.
7. Timofeeva OA, Zhang X, Ressom HW, et al. Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men. Int J Oncol 2009; 35: 751-60.
8. Rose AE, Satagopan JM, Oddoux C, et al. Copy number and gene expression differences between African American and Caucasian American prostate cancer. J Transl Med 2010; 8: 70.
9. Bonilla C, Hooker S, Mason T, et al. Prostate cancer susceptibility Loci identified on chromosome 12 in african americans. PLoS One 2011; 6: e16044.
10. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell 2000; 100: 57-70.
11. LaTulippe E, Satagopan J, Smith A, et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 2002; 62: 4499-506.
12. Sboner A, Demichelis F, Calza S, et al. Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics 2010; 3: 8.
13. Engels B, Rowley DA, Schreiber H,. Targeting stroma to treat cancers. Semin Cancer Biol 2012; 22: 41-9.
14. Micke P, Ostman A,. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 2004; 45 (Suppl 2): S163-S175.
15. Pietras K, Ostman A,. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 2010; 316: 1324-31.
16. Jia Z, Wang Y, Sawyers A, et al. Diagnosis of prostate cancer using differentially expressed genes in stroma. Cancer Res 2011; 71: 2476-87.
17. Stuart RO, Wachsman W, Berry CC, et al. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc Natl Acad Sci U S A 2004; 101: 615-20.
18. Wang Y, Xia XQ, Jia Z, et al. In silico estimates of tissue components in surgical samples based on expression profiling data. Cancer Res 2010; 70: 6448-55.
19. Greene FL,. The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg 2002; 87: 13-15.
20. Le Meur N, Gentleman R,. Analyzing biological data using R: methods for graphs and networks. Methods Mol Biol 2012; 804: 343-73.
21. Simon R, Lam A, Li MC, et al. Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 2007; 3: 11-17.
22. Wolfinger RD, Gibson G, Wolfinger ED, et al. Assessing gene significance from cDNA microarray expression data via mixed models. J Comput Biol 2001; 8: 625-37.
23. Dennis G, Jr, Sherman BT, Hosack DA, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3.
24. Barczyk M, Carracedo S, Gullberg D,. Integrins. Cell Tissue Res 2010; 339: 269-80.
25. Josson S, Matsuoka Y, Chung LW, et al. Tumor-stroma co-evolution in prostate cancer progression and metastasis. Semin Cell Dev Biol 2010; 21: 26-32.
26. Le Guelte A, Dwyer J, Gavard J,. Jumping the barrier: VE-cadherin, VEGF and other angiogenic modifiers in cancer. Biol Cell 2011; 103: 593-605.
27. Schluterman MK, Chapman SL, Korpanty G, et al. Loss of fibulin-5 binding to beta1 integrins inhibits tumor growth by increasing the level of ROS. Dis Model Mech 2010; 3: 333-42.
28. Sureshbabu A, Okajima H, Yamanaka D, et al. IGFBP-5 induces cell adhesion, increases cell survival and inhibits cell migration in MCF-7 human breast cancer cells. J Cell Sci 2012; 125 (Part 7): 1693-705.
29. Vicente-Manzanares M, Webb DJ, Horwitz AR,. Cell migration at a glance. J Cell Sci 2005; 118: 4917-19.
30. Vicente-Manzanares M, Horwitz AR,. Cell migration: an overview. Methods Mol Biol 2011; 769: 1-24.
31. Horner MJ, Ries LAG, Krapcho M, et al., eds. SEER cancer statistics review. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2007, 1975-2006.
32. Zitvogel L, Tesniere A, Kroemer G,. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006; 6: 715-27.
33. Johansson M, Denardo DG, Coussens LM,. Polarized immune responses differentially regulate cancer development. Immunol Rev 2008; 222: 145-54.
34. Callahan MJ, Nagymanyoki Z, Bonome T, et al. Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. Clin Cancer Res 2008; 14: 7667-73.